+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Mid-Size Pharmaceutical Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Drug Development Type, Formulation, and Therapy Class

  • PDF Icon

    Report

  • 73 Pages
  • September 2022
  • Region: Europe
  • The Insight Partners
  • ID: 5668322
Description Jump to:
The mid-size pharmaceutical market in Europe is expected to grow from US$ 201,707.89 million in 2022 to US$ 288,168.27 million by 2028; it is estimated to grow at a CAGR of 6.1% from 2022 to 2028.

The mid-size pharmaceutical market in Europe is characterized by the presence of various market players. To increase their market share, the players adopt various strategies such as product launches, regional expansion, and technological advancements. Leading players invest in R&D to develop advanced technologies and gain revenue. Europe accounts for the second-largest market share and is anticipated to register a significant growth rate over the forecast period. The market growth in this region is attributed to the increasing number of product launches and the growing prevalence of chronic diseases. Further, increased government expenditures on the healthcare sector favor the entry of new players in the mid-size pharmaceutical market in this region. However, the cutthroat competition among market players hinders the market growth.

By introducing new features and technologies, vendors in the Europe mid-size pharmaceutical market can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the market growth at a good CAGR during the forecast period.

Europe Mid-Size Pharmaceutical Market Segmentation

The Europe mid-size pharmaceutical market is segmented on the basis of type, drug development type, formulation, therapy class, and country.
  • Based on type, the Europe mid-size pharmaceutical market is bifurcated into prescription and over-the-counter. In 2022, the over-the-counter segment accounted for a larger market share.
  • Based on drug development type, the market is bifurcated into in-house and outsource. The outsource segment held a larger market share in 2022.
  • Based on formulation, the Europe mid-size pharmaceutical market is segmented into tablets and capsules, injectables, sprays, and other formulations. The tablets & capsules segment held the largest market share in 2022.
  • Based on therapy class, the market is segmented into cardiovascular diseases, pain management, diabetes, cancer, and other conditions. The diabetes segment held the largest market share in 2022.
  • Based on country, the Europe mid-size pharmaceutical market is segmented into Germany, France, the UK, Italy, Spain, and Rest of Europe. Germany held the largest market share in 2022.
Alexion Pharmaceuticals, Inc.; Bausch Health Companies Inc.; Daiichi Sankyo Company Limited; Eisai Co., Ltd.; Endo Pharmaceuticals Inc.; Les Laboratories Servier; Mallinckrodt; Regeneron Pharmaceuticals, Inc; Sun Pharmaceutical Industries Ltd; and UCB S.A. are among the leading companies operating in the mid-size pharmaceutical market in the region.

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Mid-Size Pharmaceutical - By Type
1.3.2 Europe Mid-Size Pharmaceutical - By Drug Development Type
1.3.3 Europe Mid-Size Pharmaceutical - By Formulation
1.3.4 Europe Mid-Size Pharmaceutical - By Therapy Area
1.3.5 Europe Mid-Size Pharmaceutical - By Country
2. Mid-Size Pharmaceutical- Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Mid-Size Pharmaceutical - Market Landscape
4.1 Overview
4.2 Europe PEST Analysis
4.3 Expert Opinion
5. Mid-Size Pharmaceutical Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Chronic Disorders
5.1.2 Increasing Product Approval and Launches
5.2 Market Restraints
5.2.1 Cutthroat Competition among Market Players
5.3 Market Opportunities
5.3.1 Rising Number of Healthcare Start-ups
5.4 Future Trends
5.4.1 Greater Focus on R&D
5.5 Impact Analysis
6. Mid-Size Pharmaceutical Market- Europe Analysis
6.1 Europe Mid-Size Pharmaceutical Market Revenue Forecast and Analysis
7. Europe Mid-Size Pharmaceutical Market Revenue and Forecasts To 2028- by Type
7.1 Overview
7.2 Europe Mid-Size Pharmaceutical Market Revenue Share, by Type (2022 and 2028)
7.3 Prescription
7.3.1 Overview
7.3.2 Prescription: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Over-the-Counter (OTC)
7.4.1 Overview
7.4.2 Over-the-Counter: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
8. Europe Mid-Size Pharmaceutical Market Analysis - By Drug Development Type
8.1 Overview
8.2 Europe Mid-Size Pharmaceutical Market Revenue Share, by Drug Development Type (2022 and 2028)
8.3 In-House
8.3.1 Overview
8.3.2 In-House: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Outsource
8.4.1 Overview
8.4.2 Outsource: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
9. Europe Mid-Size Pharmaceutical Market - By Formulation
9.1 Overview
9.2 Europe Mid-Size Pharmaceutical Market, by Formulation, 2022 and 2028 (%)
9.3 Tablets and Capsules
9.3.1 Overview
9.3.2 Tablets and Capsules: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Injectables
9.4.1 Overview
9.4.2 Injectables: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Sprays
9.5.1 Overview
9.5.2 Sprays: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
9.6 Other Formulations
9.6.1 Overview
9.6.2 Others: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
10. Europe Mid-Size Pharmaceutical Market - By Therapy Class
10.1 Overview
10.2 Europe Mid-Size Pharmaceutical Market, by Therapy Class, 2022 and 2028 (%)
10.3 Cardiovascular Diseases
10.3.1 Overview
10.3.2 Cardiovascular Diseases: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
10.4 Pain Management
10.4.1 Overview
10.4.2 Pain Management: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
10.5 Diabetes
10.5.1 Overview
10.5.2 Diabetes: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
10.6 Cancer
10.6.1 Overview
10.6.2 Cancer: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
10.7 Other Diseases
10.7.1 Overview
10.7.2 Other Diseases: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
11. Europe Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 - Country Analysis
11.1 Overview
11.1.1 Europe: Mid-Size Pharmaceutical Market, by Country, 2021 & 2028 (%)
11.1.1.1 Germany: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.1 Overview
11.1.1.1.2 Germany: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.3 Germany: Mid-Size Pharmaceutical Market, by Type - Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.4 Germany: Mid-Size Pharmaceutical Market, by Drug Development Type- Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.5 Germany: Mid-Size Pharmaceutical Market, by Formulation - Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.6 Germany: Mid-Size Pharmaceutical Market, by Therapy Area - Revenue and Forecast to 2028 (US$ Million)
11.1.1.2 France: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.1 Overview
11.1.1.2.2 France: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.3 France: Mid-Size Pharmaceutical Market, by Type - Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.4 France: Mid-Size Pharmaceutical Market, by Drug Development Type- Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.5 France: Mid-Size Pharmaceutical Market, by Formulation - Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.6 France: Mid-Size Pharmaceutical Market, by Therapy Area - Revenue and Forecast to 2028 (US$ Million)
11.1.1.3 UK: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.1 Overview
11.1.1.3.2 UK: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.3 UK: Mid-Size Pharmaceutical Market, by Type - Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.4 UK: Mid-Size Pharmaceutical Market, by Drug Development Type- Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.5 UK: Mid-Size Pharmaceutical Market, by Formulation - Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.6 UK: Mid-Size Pharmaceutical Market, by Therapy Area - Revenue and Forecast to 2028 (US$ Million)
11.1.1.4 Italy: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
11.1.1.4.1 Overview
11.1.1.4.2 Italy: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
11.1.1.4.3 Italy: Mid-Size Pharmaceutical Market, by Type - Revenue and Forecast to 2028 (US$ Million)
11.1.1.4.4 Italy: Mid-Size Pharmaceutical Market, by Drug Development Type- Revenue and Forecast to 2028 (US$ Million)
11.1.1.4.5 Italy: Mid-Size Pharmaceutical Market, by Formulation - Revenue and Forecast to 2028 (US$ Million)
11.1.1.4.6 Italy: Mid-Size Pharmaceutical Market, by Therapy Area - Revenue and Forecast to 2028 (US$ Million)
11.1.1.5 Spain: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
11.1.1.5.1 Overview
11.1.1.5.2 Spain: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
11.1.1.5.3 Spain: Mid-Size Pharmaceutical Market, by Type - Revenue and Forecast to 2028 (US$ Million)
11.1.1.5.4 Spain: Mid-Size Pharmaceutical Market, by Drug Development Type- Revenue and Forecast to 2028 (US$ Million)
11.1.1.5.5 Spain: Mid-Size Pharmaceutical Market, by Formulation - Revenue and Forecast to 2028 (US$ Million)
11.1.1.5.6 Spain: Mid-Size Pharmaceutical Market, by Therapy Area - Revenue and Forecast to 2028 (US$ Million)
11.1.1.6 Rest of Europe: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
11.1.1.6.1 Overview
11.1.1.6.2 Rest of Europe: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (US$ Million)
11.1.1.6.3 Rest of Europe: Mid-Size Pharmaceutical Market, by Type - Revenue and Forecast to 2028 (US$ Million)
11.1.1.6.4 Rest of Europe: Mid-Size Pharmaceutical Market, by Drug Development Type- Revenue and Forecast to 2028 (US$ Million)
11.1.1.6.5 Rest of Europe: Mid-Size Pharmaceutical Market, by Formulation - Revenue and Forecast to 2028 (US$ Million)
11.1.1.6.6 Rest of Europe: Mid-Size Pharmaceutical Market, by Therapy Area - Revenue and Forecast to 2028 (US$ Million)
12. Mid-Size Pharmaceutical Market-Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 DAIICHI SANKYO COMPANY LIMITED
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Eisai Co., Ltd.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Bausch Health Companies Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Regeneron Pharmaceuticals, Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Sun Pharmaceutical Industries Ltd
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Alexion Pharmaceuticals, Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Mallinckrodt
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Endo Pharmaceuticals Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Les Laboratories Servier
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 UCB S.A.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About the Publisher
14.2 Glossary of Terms

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Alexion Pharmaceuticals, Inc.
  • Bausch Health Companies Inc.
  • Daiichi Sankyo Company Limited
  • Eisai Co., Ltd.
  • Endo Pharmaceuticals Inc.
  • Les Laboratories Servier
  • Mallinckrodt
  • Regeneron Pharmaceuticals, Inc
  • Sun Pharmaceutical Industries Ltd
  • UCB S.A.

Table Information

Report AttributeDetails
No. of Pages73
PublishedSeptember 2022
Forecast Period2022 - 2028
Estimated Market Value ( USD ) in 2022 $ 201707.89 Million
Forecasted Market Value ( USD ) by 2028 $ 288168.27 Million
Compound Annual Growth Rate6.1%
Regions CoveredEurope

Related Topics

Related Reports

Global Pharmaceutical Manufacturing Market by Formulation (Capsules, Injectable, Powders), Drug Development Type (In-House, Outsource), Route of Administration, Drugs, Age Group, Distribution Channel, Therapy Area - Forecast 2024-2030 - Product Image

Global Pharmaceutical Manufacturing Market by Formulation (Capsules, Injectable, Powders), Drug Development Type (In-House, Outsource), Route of Administration, Drugs, Age Group, Distribution Channel, Therapy Area - Forecast 2024-2030

  • Report
  • 187 Pages
  • Global
From
Global Vesicular Transporter Assay Market by Type (Colorimetric Assays, Fluorescence-Based Assays, Radioactive Assays), Application (Drug Development, Neurological Research, Toxicological Assessment), End-use - Forecast 2024-2030 - Product Image

Global Vesicular Transporter Assay Market by Type (Colorimetric Assays, Fluorescence-Based Assays, Radioactive Assays), Application (Drug Development, Neurological Research, Toxicological Assessment), End-use - Forecast 2024-2030

  • Report
  • 192 Pages
  • Global
From
Monocyte Activation Tests Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Source, Products, and Application [Drug Development, Vaccine Development, Medical Devices, and Others] - Product Image

Monocyte Activation Tests Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Source, Products, and Application [Drug Development, Vaccine Development, Medical Devices, and Others]

  • Report
  • 150 Pages
  • Global
From
Europe Drug Discovery Informatics Market Size, Share & Trends Analysis Report By Application (Drug Discovery, and Drug Development), By Function, By End User, By Country and Growth Forecast, 2024 - 2031 - Product Image

Europe Drug Discovery Informatics Market Size, Share & Trends Analysis Report By Application (Drug Discovery, and Drug Development), By Function, By End User, By Country and Growth Forecast, 2024 - 2031

  • Report
  • 140 Pages
  • Europe
From
Global Drug Discovery Informatics Market Size, Share & Trends Analysis Report By Application (Drug Discovery, and Drug Development), By Function, By End User, By Regional Outlook and Forecast, 2024 - 2031 - Product Image

Global Drug Discovery Informatics Market Size, Share & Trends Analysis Report By Application (Drug Discovery, and Drug Development), By Function, By End User, By Regional Outlook and Forecast, 2024 - 2031

  • Report
  • 264 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.